Statistik
Effectiveness of XBB.1.5 Vaccines Against Symptomatic SARS-CoV-2 Infection in Older Adults During the JN.1 Lineage-Predominant Period, European VEBIS Primary Care Multicentre Study, 20 November 2023–1 March 2024
| Zugriffe | |
|---|---|
| Effectiveness ... | 196 |
Gesamtzugriffe pro Monat
| März 2026 | April 2026 | Mai 2026 | Juni 2026 | Juli 2026 | August 2026 | September 2026 | |
|---|---|---|---|---|---|---|---|
| Effectiveness ... | 31 | 28 | 14 | 20 | 20 | 46 | 37 |
Dateiabrufe
| Zugriffe | |
|---|---|
| Influenza Resp Viruses - 2024 - Merdrignac - Effectiveness of XBB 1 5 Vaccines Against Symptomatic SARS‐CoV‐2 Infection in.pdf | 91 |